Stanley TL et al., "Effects of tesamorelin on non-alcoholic fatty liver disease in HIV: a randomised, double-blind, multicentre trial," The Lancet HIV, 2019
A small molecule inhibitor of Nicotinamide N-methyltransferase for the treatment of metabolic disorders
Where Phase I or Phase II human trials exist, they are noted in the compound page summary
These catalogs may include additional compounds such as: ghk-cu peptides bpc-157 research materials tesamorelin peptide semax peptide ipamorelin blends Access to multiple compounds simplifies procurement and improves workflow efficiency
Skin and subcutaneous adipose layer thickness in adults with diabetes at sites used for insulin injections: implications for needle length recommendations Shorter needles are also less painful, because they penetrate less tissue: The needle lengths that were once recommended for SC injection (for adults, 8 mm
Molecular cloning of a novel esterase involved in the metabolic activation of arylamine carcinogens with high sequence similarity to hormone-sensitive lipase